ClinicalTrials.gg
RecruitingNCT07233304Updated Nov 18, 2025

Complications of the Alveolar Opening Maneuver in Children on Mechanical Ventilation

An observational study in Positive End-expiratory Pressure (PEEP), Oxygenation Index and Pediatric Intensive Care Unit, sponsored by Hospital de Alta Complejidad en Red. Recruiting at 1 site in Argentina. Open to participants aged 1 Month to 14 Years. Per ClinicalTrials.gov, last updated 2025-11-18.

Sponsored by Hospital de Alta Complejidad en Red · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
143
Ages
1 Month to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Respiratory Distress Syndrome with a site in Argentina — 6 open to participants now, 7 under way, 1 of them phase 3. Respiratory Distress Syndrome · Argentina.

Planned enrollment
2nd of 12
143 · median 40
Started
2025
with 1 other
Observational
12 of 21
4 open now
Registered
21st of 21
by date
Lead sponsor
1 of 21
Hospital de Alta Complejidad en Red

Among the 21 studies in Respiratory Distress Syndrome with a site in Argentina, this one is the 2nd largest by planned enrollment of the 12 observational ones that give a count, is one of 2 that started in 2025, is one of 12 observational ones, and was the 21st registered.

Respiratory Distress Syndrome

1,388 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.

Browse Respiratory Distress Syndrome studies →

Open to participants now

6 of the 21 studies in Respiratory Distress Syndrome with a site in Argentina are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Argentina have not opened yet or have stopped. Only those recruiting at a site in Argentina →

Who these studies take

Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.

This study: 1 Month to 14 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Respiratory Distress Syndrome with a site in Argentina, or all of them as a file.
02

Study summary

The objective of this research is to analyze the overall incidence of complications associated with a therapeutic maneuver known as alveolar opening and subsequent titration of positive end-expiratory pressure (PEEP) in pediatric patients with acute respiratory distress syndrome (ARDS). These procedures are part of the standard care provided in the Pediatric Intensive Care Unit (PICU) and are used to improve pulmonary oxygenation and respiratory mechanics. Through this study, we aim to gather information that will help improve the safety and effectiveness of these interventions in critically ill patients.

Read the detailed description

Objective

To analyze the overall incidence of complications associated with alveolar opening maneuvers and PEEP in pediatric patients with respiratory distress syndrome.

Materials and Methods

Study setting A prospective cohort study will be conducted between April and September in the Pediatric Intensive Care Unit (PICU) of the Hospital Cuenca Alta Néstor Kirchner (HCANK).

Sample All patients meeting the eligibility criteria will be included. An estimated total of 143 maneuvers involving alveolar opening maneuversand PEEP are to be analyzed, as these procedures are part of the standard care in managing ventilated patients with ARDS and are included in the institutional protocol (see Appendix).

Inclusion criteria:

  • Patients under 14 years of age admitted to the HCANK PICU
  • More than 4 hours of invasive mechanical ventilation (IMV)
  • An oxygenation index (OI) ≥4 or an oxygen saturation index (OSI) ≥5
  • Indication for alveolar opening maneuvers and PEEP as determined by the treating team

Exclusion criteria:

  • Predicted body weight (PBW) >45.5 kg
  • Recent pulmonary resection surgery (\<7 days)
  • Presence of broncho-pleural fistula or peri-tube leak >25% of the tidal volume
  • Hemoglobin decline \<7 g/dL
  • Patients with congenital or acquired heart diseases with significant intracardiac shunt

Variables:

Outcome variable:

- Overall incidence of complications related to alveolar opening maneuvers and PEEP

Procedure Once patients are included, demographic, clinical, and relevant background data will be recorded in a dedicated data sheet. Following this, study evaluators will record baseline clinical data from the multiparameter monitor prior to performing the alveolar opening maneuvers and PEEP procedures. Relevant values will be obtained from the advanced monitoring sheet completed by the treating team.

During the alveolar opening maneuvers and PEEP procedures, intra-procedural complications will be noted, and monitoring will continue for 4 hours after the procedure to observe for any complications that develop.

If, due to intercurrences or the treating team's decision, the alveolar opening maneuvers and PEEP need to be repeated before 4 hours, monitoring will still continue for 4 hours after the last maneuver.

Statistical Analysis Categorical variables will be described using absolute numbers and percentages of the total, while continuous variables will be expressed using measures of central tendency and dispersion or position, depending on their distribution.

The Kolmogorov-Smirnov test will be used as a goodness-of-fit test to determine the distribution of numerical variables.

To address the objective, the overall incidence of complications will be calculated, with estimates and 95% confidence intervals provided.

Data analysis will be performed using IBM SPSS Windows version 25.0 (IBM Corp., Armonk, NY, USA), R version 3.6.3 (R Core Team, 2020), and the ggplot2 package version 3.3.2 (Wickham, 2016) for graph creation.

Sample size calculation The calculation assumes a null hypothesis where the incidence of complications after alveolar opening maneuvers and PEEP is 5%, based on previously reported data indicating a lower rate of complications.

The alternative hypothesis posits that the incidence of complications related to alveolar opening maneuvers and PEEP is less than 5%.

A total of 143 maneuvers are planned to be recruited according to the sample size calculation based on these hypothesized values.

03

Conditions studied

  • Positive End-expiratory Pressure (PEEP)
  • Oxygenation Index
  • Pediatric Intensive Care Unit
  • Pediatric Acute Lung Injury
  • Respiratory Distress Syndrome, Pediatric
  • Complication
04

Who can participate

Ages eligible
1 Month to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients under 14 years of age admitted to the Pediatric Intensive Care Unit (PICU) of the Hospital Cuenca Alta Néstor Kirchner

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients under 14 years of age admitted to the HCANK PICU
  • More than 4 hours of invasive mechanical ventilation (IMV)
  • An oxygenation index (OI) ≥4 or an oxygen saturation index (OSI) ≥5
  • Indication for ARM and PEEP as determined by the treating team

Exclusion criteria

Exclusion criteria:

  • Predicted body weight (PBW) >45.5 kg
  • Recent pulmonary resection surgery (\<7 days)
  • Presence of broncho-pleural fistula or peri-tube leak >25% of the tidal volume
  • decline \<7 g/dL
  • Patients with congenital or acquired heart diseases with significant intracardiac shunt.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
143 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Alveolar Opening Maneuver and PEEP Titration (AOM+P)

    Patients under invasive mechanical ventilation for pediatric acute respiratory distress syndrome (PARDS) who undergo a standardized alveolar opening maneuver followed by decremental PEEP titration according to institutional protocol. The maneuver consists of stepwise increases in PEEP until reaching a plateau pressure of 35 cmH₂O (or up to 40 cmH₂O in patients with reduced chest wall compliance), maintained for 2 minutes, followed by decremental PEEP titration to determine the optimal level based on driving pressure and oxygen saturation. The procedure is performed once clinically indicated, with continuous hemodynamic and oxygenation monitoring.

    Procedure: Alveolar Opening Maneuver and PEEP Titration (AOM+P)

Interventions

  • ProcedureAlveolar Opening Maneuver and PEEP Titration (AOM+P)

    Standardized ventilatory procedure performed in pediatric patients under invasive mechanical ventilation with acute respiratory distress syndrome (PARDS). The intervention consists of a controlled alveolar opening maneuver with stepwise PEEP increments up to a plateau pressure of 35 cmH₂O (or up to 40 cmH₂O in patients with reduced chest wall compliance), maintained for 2 minutes, followed by a decremental PEEP titration to determine the optimal PEEP level based on driving pressure and oxygenation response. The procedure is performed once clinically indicated, under continuous hemodynamic and oxygen monitoring, according to the institutional safety protocol.

    Also known as: Alveolar Opening Protocol, PEEP Titration Procedure, AOM+P Institutional Protocol

06

What researchers measure

Primary outcomes

  1. Overall incidence of complications related to the alveolar opening maneuver and PEEP titration

    The number and proportion of patients who develop any adverse event directly associated with the alveolar opening maneuver or PEEP titration within 4 hours after the procedure. Complications may include hemodynamic instability (e.g., hypotension, bradycardia), oxygen desaturation, barotrauma (such as pneumothorax), or cardiac arrhythmias observed during or after the intervention.

    Time frame: 4 hours post-procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2026, 12 months after the start.

Of 228 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 234 studies reached it within 24 months; a quarter within 12 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 18, 2025
StartActual
Aug 18, 2025
Primary completionEst.
Aug 2026
CompletionEst.
Aug 2026
Last update
Nov 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07233304
Lead sponsor
Hospital de Alta Complejidad en Red
Responsible party
Belen Castelli (Physical Therapy, Hospital de Alta Complejidad en Red) — Principal investigator
First posted
Nov 18, 2025
Start date
Aug 18, 2025
Primary completion
Aug 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Nov 18, 2025

Study contacts

Maria Belén B castelli, BCS
Contact
investigacion@hospitalcuencaalta.org.ar
+54 2227442582
Jose Garcia Urrutia, BCS
principal investigator · Hospital de Alta Complejidad Cuenca Alta "Néstor Kirchner", Buenos Aires, Argentina
Belen Castelli, BCS
principal investigator · Hospital de Alta Complejidad Cuenca Alta "Néstor Kirchner", Buenos Aires, Argentina

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion